These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

76 related items for PubMed ID: 309464

  • 1. [Juvenile Sharp syndrome (mixed connective tissue disease)].
    Rosenthal M.
    Helv Paediatr Acta; 1978 Aug; 33(3):251-8. PubMed ID: 309464
    [Abstract] [Full Text] [Related]

  • 2. [Mixed connective tissue disease in childhood].
    Yokota S.
    Ryumachi; 1994 Dec; 34(6):947-54. PubMed ID: 7863384
    [Abstract] [Full Text] [Related]

  • 3. [The Sharp syndrome ("mixed connective tissue disease")].
    Rosenthal M.
    Schweiz Med Wochenschr; 1976 Jan 31; 106(5):129-34. PubMed ID: 1082643
    [Abstract] [Full Text] [Related]

  • 4. [The clinical significance of soluble nuclear antigen specific antibodies (author's transl)].
    Peltier AP, Gaudreau A, Amor B, Kahn MF, Ryckewaert A, Sany J, Haim T.
    Nouv Presse Med; 1978 May 27; 7(21):1813-8. PubMed ID: 307737
    [Abstract] [Full Text] [Related]

  • 5. Mixed connective tissue disease syndrome.
    Gilliam JN, Prystowsky SD.
    Arch Dermatol; 1977 May 27; 113(5):583-7. PubMed ID: 67824
    [Abstract] [Full Text] [Related]

  • 6. [Sharp's syndrome. Clinical, immunological and nosographic aspects].
    Scagliusi P, Muratore M, Martiradonna A, Berlingerio G, Carrozzo M.
    Minerva Med; 1980 Dec 15; 71(50):3655-63. PubMed ID: 6161325
    [Abstract] [Full Text] [Related]

  • 7. Antibodies against distinct nuclear matrix proteins are characteristic for mixed connective tissue disease.
    Habets WJ, de Rooij DJ, Salden MH, Verhagen AP, van Eekelen CA, van de Putte LB, van Venrooij WJ.
    Clin Exp Immunol; 1983 Oct 15; 54(1):265-76. PubMed ID: 6352106
    [Abstract] [Full Text] [Related]

  • 8. Antibody to extractable nuclear antigen in the rheumatic diseases.
    McCain GA, Bell DA, Chodirker WB, Komar RR.
    J Rheumatol; 1978 Oct 15; 5(4):399-406. PubMed ID: 310883
    [Abstract] [Full Text] [Related]

  • 9. [Significance of speckled staining of epidermal nuclei in direct immunofluorescence. 10 cases (author's transl)].
    Morel P, Peltier AP, Allegre P, Civatte J.
    Nouv Presse Med; 1978 Oct 15; 7(27):2377-80. PubMed ID: 353722
    [Abstract] [Full Text] [Related]

  • 10. In vivo anti-nuclear antibodies in epithelial biopsies in SLE and other connective tissue diseases.
    Wells JV, Webb J, Van Deventer M, Fry B, Pollard KM, Raftos J, Monk W, Nelson DS.
    Clin Exp Immunol; 1979 Dec 15; 38(3):424-35. PubMed ID: 394890
    [Abstract] [Full Text] [Related]

  • 11. Distribution of IgG subclass antibodies anti-ENA (extractable nuclear antigens) in systemic rheumatic diseases.
    Sánchez Ibarrola A, Valdivieso R, Wong E, Sánchez Arroyo R.
    Allergol Immunopathol (Madr); 1987 Dec 15; 15(4):195-200. PubMed ID: 3500626
    [Abstract] [Full Text] [Related]

  • 12. Mixed connective tissue disease.
    Prystowsky SD.
    West J Med; 1980 Apr 15; 132(4):288-93. PubMed ID: 7385833
    [Abstract] [Full Text] [Related]

  • 13. Mixed connective tissue disease.
    Minkin W, Rabhan N.
    Arch Dermatol; 1976 Nov 15; 112(11):1535-8. PubMed ID: 1086651
    [Abstract] [Full Text] [Related]

  • 14. [Mixed connective tissue disease (Sharp syndrome)].
    Lang H, Gläser V, Hourieh M.
    Z Gesamte Inn Med; 1980 Nov 15; 35(22):824-8. PubMed ID: 6970457
    [Abstract] [Full Text] [Related]

  • 15. Epidermal nuclear immunoglobulin deposition in connective tissue diseases.
    Rodrigues CJ, de Oliveira RM, Taniwaki NN, Bueno C, Marchiori P, Cossermelli W.
    Rev Hosp Clin Fac Med Sao Paulo; 1990 Nov 15; 45(4):154-7. PubMed ID: 2135825
    [Abstract] [Full Text] [Related]

  • 16. Antibodies against extractable nuclear antigens (ENA) in systemic scleroderma.
    Jabłońska S, Błaszczyk M, Górkiewicz A, Jarzabek-Chorzelska M, Rzesa G, Chorzelski T.
    Arch Immunol Ther Exp (Warsz); 1978 Nov 15; 26(1-6):765-8. PubMed ID: 312085
    [Abstract] [Full Text] [Related]

  • 17. Clinical characteristics and course in patients with high titer anti-RNP antibodies.
    Lemmer JP, Curry NH, Mallory JH, Waller MV.
    J Rheumatol; 1982 Nov 15; 9(4):536-42. PubMed ID: 6982334
    [Abstract] [Full Text] [Related]

  • 18. Antibodies to components of extractable nuclear antigen. Clinical characteristics of patients.
    Farber SJ, Bole GG.
    Arch Intern Med; 1976 Apr 15; 136(4):425-31. PubMed ID: 1083722
    [Abstract] [Full Text] [Related]

  • 19. In vivo antinuclear antibodies (ANA) in biopsies of normal skin: diagnostic significance and relation to serum ANA.
    Kallenberg CG, de Jong MC, Walstra TM, Kardaun S, The TH.
    J Rheumatol; 1983 Oct 15; 10(5):733-40. PubMed ID: 6606041
    [Abstract] [Full Text] [Related]

  • 20. Clinical usefulness of antibodies to U1snRNP proteins in mixed connective tissue disease and systemic lupus erythematosus.
    Margaux J, Hayem G, Palazzo E, Chazerain P, De Bandt M, Haim T, Kahn MF, Meyer O.
    Rev Rhum Engl Ed; 1998 Jun 15; 65(6):378-86. PubMed ID: 9670329
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.